US Stock MarketDetailed Quotes
HLVX HilleVax
- 1.960
- -0.020-1.01%
Close Dec 13 16:00 ET
- 1.960
- 0.0000.00%
Post 16:20 ET
97.62MMarket Cap-0.63P/E (TTM)
1.990High1.950Low239.13KVolume1.990Open1.980Pre Close470.93KTurnover0.80%Turnover RatioLossP/E (Static)49.81MShares20.22052wk High0.53P/B58.65MFloat Cap1.55052wk Low--Dividend TTM29.92MShs Float24.420Historical High--Div YieldTTM2.02%Amplitude1.550Historical Low1.969Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
HilleVax Stock Forum
📊⚡️📊
On a day that saw its stock plummet by 84%, closing at $2.25, HilleVax, Inc. (Nasdaq: HLVX) announced the topline data results from its NEST-IN1 clinical study. This notable decline followed the announcement that the NEST-IN1 study did not meet its primary or secondary efficacy endpoints, leading the company to discontinue further dev...
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
HilleVax announced topline results from the NEST-IN1 Phase 2b study of HIL-214 in infants. The trial, conducted in the US and Latin America, did not meet its primary or secondary efficacy endpoints. Specifically, the vaccine showed a mere 5% efficacy against moderate or severe acute gastroenteritis caused by norovirus, which was statistically insignificant. Consequently, HilleVax wil...
No comment yet